Conventional wisdom regarding mechanisms of bacterial pathogenesis holds that pathogens arise by external acquisition of distinct virulence factors, whereas determinants shared by pathogens and commensals are considered to be functionally equivalent and have been ignored as genes that could become adapted specifically for virulence. It is shown here, however, that genetic variation in an originally commensal trait, the FimH lectin of type 1 fimbriae, can change the tropism of Escherichia coli, shifting it toward a urovirulent phenotype. Random point mutations in fimH genes that increase binding of the adhesin to mono-mannose residues, structures abundant in the oligosaccharide moieties of urothelial glycoproteins, confer increased virulence in the mouse urinary tract. These mutant FimH variants, however, are characterized by increased sensitivity to soluble inhibitors bathing the oropharyngeal mucosa, the physiological portal of E. coli. This functional trade-off seems to be detrimental for the intestinal ecology of the urovirulent E. coli. Thus, bacterial virulence can be increased by random functional mutations in a commensal trait that are adaptive for a pathologic environment, even at the cost of reduced physiological fitness in the nonpathologic habitat.
In the prevailing view of bacterial pathogenesis, evolutionary adaptation to the pathologic habitat is due to the possession by pathogens of virulence factor genes that are absent from commensal strains (1) . Although it is well known that natural variation of allelic genes leads to the expression of distinct protein variants (i.e., protein polymorphism) (2) , heteroalleles in a haploid organism are generally considered to be functionally equivalent and, therefore, selectively neutral (3, 4) . The exceptions to this rule are highly divergent genes, often of mosaic structure, which are under strong directional selection, as are the genes for resistance to antibiotics and genes maintained by frequency-dependent selection induced by the host immune system (5) (6) (7) (8) . The transition, however, from commensal to virulent phenotype has been attributed to the acquisition of distinct ''virulence genes.'' To date, conventional wisdom regarding molecular mechanisms of microbial specialization as pathogens has essentially excluded genes shared by pathogenic and commensal strains from consideration as factors that could become adapted specifically for pathogenicity.
Escherichia coli inhabit the large intestine of humans and other animals as a small but consistent part of the normal microbiota. This primary niche also serves as a reservoir for E. coli that can cause a variety of enteric and extra-enteric diseases (9) . One trait that has been considered important for both normal ecology and for pathogenicity is the production of tissue-specific adhesive factors, frequently found in the form of hair-like surface structures called fimbriae. More than 95% of all isolates of E. coli express type 1 fimbriae, which are also called mannose-sensitive or common fimbriae (10, 11) . Expression of type 1 fimbriae may not be required for maintaining E. coli in the colon (12, 13) , but they do provide E. coli with a significant advantage for the transitory colonization of the oropharyngeal portal that is important for the normal fecal/ oral transmission of E. coli among individual hosts (13, 14) . In addition to this essential role in commensal ecology, type 1 fimbriae are also important for the pathogenesis of urinary tract infections (UTIs) (15, 16) . The D-mannose-sensitive adhesive phenotype of type 1 fimbriae is dependent on the lectin-like activity of a tip-located 30-kDa subunit, FimH (17, 18) . Naturally occurring phenotypic variants of the FimH protein have recently been recognized (19, 20) . All fimH alleles studied to date encode subunits that mediate high levels of binding to tri-mannose structures (M 3 ; ␣1-3, ␣1-6-Dmannotriose), but binding to mono-mannose (M 1 ) residues among the FimH variants can differ up to 15-fold (21) . These adhesive variations are due solely to structural differences in FimH that affect receptor specificity of the lectin but do not affect fimbrial morphology or level of fimbriation (20, 21) . Thus, all type 1 fimbriae can be functionally subdivided into either low M 1 -binding (M 1 L) or high M 1 -binding (M 1 H) FimH phenotypes. E. coli exhibiting these two basic phenotypes have been found to predominate in different niches. Most isolates from the large intestine of healthy humans (around 80%) express a distinct M 1 L phenotype, whereas most isolates from UTIs (more than 70%) express M 1 H FimH variants (20) . The previous studies, however, did not identify selective forces that could cause the differential distribution of phenotypes in the intestinal and uropathogenic E. coli populations.
In this report, it is shown that naturally occurring FimH variations dramatically change the tissue tropism of E. coli and can be a major factor in shifting the bacterial adaptation from commensal to pathologic habitat. Thus, the transition from commensal to virulent phenotype may be mediated not only by acquisition of ''virulence genes'' but also by selection for genetic variations in a commensal trait that are adaptive to a pathologic environment.
MATERIALS AND METHODS
Construction of Isogenic Strains. The M 1 L and M 1 H phenotype strains used in binding studies (KB91 and KB96, respectively) were created as described elsewhere. Briefly, M 1 L and M 1 H fimH genes were cloned by PCR from the intestinal E. coli strain F-18 and UTI isolate MJ#2-2, respectively, subcloned into pACYC184-based plasmids creating pGB17 and pGB19, respectively, and introduced into the fimH-null E. coli strain AAEC191A (pPKL114) (20) . Strains KB91 and KB96 were assayed for M 1 and M 3 binding, utilizing immobilized monomannosylated BSA (M 1 ) and ␣1-3, ␣1-6-D-mannotriose BSA (M 3 ) as described previously (21) . The M 1 -binding levels of strain KB91 and strain KB96 were 0.52 Ϯ 0.1 ϫ 10 6 cfu per well and 4.5 Ϯ 0.52 ϫ 10 6 cfu per well, respectively, and the M 3 -binding levels were 6.5 Ϯ 0.50 ϫ 10 6 cfu per well and 7.2 Ϯ 0.62 ϫ 10 6 cfu per well, respectively. For mouse UTI experiments, isogenic strains were created using the UTI E. coli strain CI #10. This strain expresses M 1 H type 1 fimbriae and is negative for genes encoding P-related fimbriae, S/F1C fimbriae, Dr adhesin, aerobactin, groups II and III capsule, hemolysin, cytotoxic necrotizing factor I, and outer membrane protein T. The fimH gene of CI#10 was insertionally inactivated using the pCH103 suicide plasmid, as described previously (22) . Southern blots of chromosomal DNA from the fimH-null strain, CI#10-9, indicated that an appropriate double crossover event occurred (data not shown). Strain CI#10-9 was transformed with plasmids pGB17 and pGB19, described above, or with an isogenic plasmid containing a fimH gene missing a 17-bp segment at the 3Ј-end and encoding a nonfunctional form of the FimH protein. The adhesive phenotype of CI#10-9 complemented with the fimH-bearing plasmids was precisely as predicted for corresponding fimH alleles. Phylogenetic analysis was performed on fimH alleles derived from wild-type fecal and urinary isolates and one recombinant strain described previously (20) .
Binding Studies. Yeast and guinea pig red blood cell (RBC) agglutination assays were performed by mixing equal amounts of serially diluted bacterial suspensions (starting from OD 540 nm ϭ 1.0) and a 1% suspension of baking yeast or guinea pig red blood cells in U-bottom microtiter plate wells. Buccal epithelial cell binding and binding inhibition experiments were performed using an inverted adhesion assay, described previously (23) . In this assay, bacteria are immobilized in microtiter plate wells, and buccal cells are added to the bacterial substratum, thus eliminating potential interference by bacterial agglutinins. Procedures for purifying uroplaques (i.e., asymmetric unit membranes) from bovine bladder and for testing their ability to bind E. coli in microtiter plate wells were described previously (24) . Samples of saliva were obtained and treated as described previously (25) .
Experimental UTI. Female C3H/HeN mice (Harlan Laboratories, Haslett, MI) were used at 8-14 weeks of age. Overnight cultures of the recombinant strains were suspended in 0.01 M PBS (pH 7.0) to a concentration of 5 ϫ 10 9 per ml, and 0.05 ml were inoculated into bladders of the mice by transurethral catheterization under ketamine/xylazine anesthesia.
Mice were sacrificed after 24 h, and the bladders were excised and homogenized. The procedures used were approved by the University of Tennessee, Memphis Animal Care and Use Committee. Numbers of bacteria per bladder were quantitated by viable counts obtained from tissue homogenates. Plasmid stability was 100% over the course of these experiments. The Mann-Whitney u test was used for the calculation of P.
RESULTS

M 1 H Variants Exhibit Expanded Cell Receptor Specificity.
High M 1 -reactivity allows M 1 H variants to interact with a wide variety of receptor glycoproteins, whereas M 1 L variants require unsubstituted M 3 structures, thus limiting their spectrum of binding activities (21) . Mannosylated glycoproteins are common components of the surface of various cell types, so it was not surprising to find that the M 1 H variant mediated adhesion to more cellular substrata than did the M 1 L variant (Table 1 ). Whereas the M 1 L and M 1 H variants interacted at essentially the same levels with yeast cells and buccal epithelial cells, the M 1 H variant bound much more effectively to guinea pig erythrocytes and bovine bladder uroplaques. Although yeast and erythrocyte agglutination are the traditional assays used to test type 1 fimbriae, interaction with buccal cells and uroplaques are more important from a physiological perspective, regarding oropharyngeal and bladder colonization by E. coli, respectively.
M 1 H Variants Provide Selective Advantage for E. coli Colonization of the Urinary Tract. Uroplaques occupy 80% or more of the apical surface of bladder epithelial cells and are considered to be the major adhesion substratum for E. coli in the mammalian bladder (24) . We hypothesized that the greater level of binding of the M 1 H variants to these cellular components confers a selective advantage during bladder colonization. This hypothesis was tested by infecting mice with a set of strains that were isogenic, except for the expressed fimH gene. Twenty-four hours after intravesical inoculation, the recombinant strains bearing either M 1 L or M 1 H fimH genes were recovered from bladders in higher numbers than the strain encoding a nonfunctional FimH (Fig. 1) , but the colonizing ability of the M 1 H strain was at least 15-fold higher than that of the M 1 L strain. Therefore, it can be concluded that in the same genetic background of a uropathogenic isolate, the M 1 H FimH confers a significant advantage for colonization of the bladder compared with the M 1 L variant, providing a rationale for the predominance of the M 1 H FimH phenotype among UTI strains. M 1 L Phenotype Exhibits a Superior Ability to Resist Inhibitors of Adhesion. The M 1 L phenotype is predominant among intestinal E. coli. Because type 1 fimbriae are apparently not required once the bacteria enter this niche (12) , the M 1 L phenotype must provide a selective advantage in the transient colonization of the oropharyngeal portal required for inter-host transmission (13, 14) . The number of bacteria bound to mucosal cells is a function of the affinity of the adhesin for the cognate receptor on the epithelial cells and the interference of inhibitors in the body fluids bathing the mucosal surfaces (26) . The fact that E. coli expressing either phenotype of FimH interacted with buccal epithelial cells at equivalent levels suggested that any advantage provided by the M 1 L variant in the oral cavity could be the result of differences of the two variants in their sensitivity to mannose-containing inhibitors. Indeed, at relatively high concentrations of ␣-methyl-D-mannopyranoside, the binding of both variants to buccal cells is completely inhibited, but at intermediate concentrations of inhibitor, the M 1 L variant is much less sensitive to inhibition (Fig. 2) . The IC 50 of the M 1 L variant was 15-fold higher than that of the M 1 H variant. Inhibition of yeast cell agglutination followed the same pattern, with the M 1 L variant being 10-fold more resistant to inhibition.
Although the difference in mannose sensitivity of these FimH variants is striking, free mannose is rarely, if ever, found in the natural environment. Mucosal surfaces are, however, bathed with glycoproteins that possess terminally exposed mannose residues (27, 28) . It was previously shown that certain surface-immobilized glycoproteins bind both FimH variants equally well, whereas other glycoproteins bind M 1 H variants much better (21) . Model glycoproteins representing these two basic types of mannosylated receptors were tested in solution for their ability to inhibit the interaction of M 1 L and M 1 H variants with buccal cells (Table 2) . For all four glycoproteins, the concentration required to inhibit the M 1 H variant by 50% is much lower (3-to 25-fold) than those concentrations required to achieve the same level of inhibition of the M 1 L variant. Because the majority of inhibitors of E. coli adhesion in the oropharyngeal cavity are likely to be present in saliva, the ability of whole, stimulated human saliva to interfere with the interaction of the E. coli strains with buccal cells was also tested (Fig. 3) . Here again, bacteria expressing the M 1 L variant are much more resistant to inhibition. In the presence of undiluted saliva, bacteria expressing the M 1 L variant bound buccal cells in 5-fold higher numbers than did the bacteria expressing the M 1 H variant. The relatively high concentration of saliva needed to inhibit binding of the M 1 L variant to oropharyngeal cells should confer a higher rate of per os transmission of intestinal strains of E. coli and, overall, impart an increased fitness for commensal ecology. 
DISCUSSION
Based on the analyses reported here, it can be proposed that FimH polymorphism is sustained in the population by diversifying selection, a form of balancing selection where two different genotypes are positively selected in two different environments (30) . The M 1 L variants are common among intestinal E. coli, and M 1 H variants are common among UTI E. coli as a result of differential adaptation to these different niches. Importantly, adaptation of the M 1 H variants for the urinary tract is accompanied by a functional trade-off where an increasing ability of FimH adhesins to recognize additional cellular receptors results in a decreasing ability to resist inhibition by mannosylated compounds. The M 1 L variants seem to be optimized for adhesion to surfaces naturally bathed with high concentrations of soluble mannosylated compounds, such as the oropharyngeal mucosa. Interestingly, the binding of the M 1 H variant to buccal cells is inhibited to a greater extent than is the binding of the M 1 L variant by all types of soluble inhibitors tested. This was true even for soluble RNAse B and lactoferrin, to which both variants bind equally well when the glycoproteins have been immobilized, suggesting that FimH subunits might interact via different mechanisms with surface-bound and soluble forms of a glycoprotein. It is also interesting to note that the inhibitory activity of mucin against these two strains differs less drastically than the activity of other tested glycoproteins. At least a portion of the inhibitory activity of mucin could be due to nonspecific effects of its high viscosity. The same nonspecific effect could be responsible for the relatively small differences in the IC 50 of saliva. The molecular details of these phenomena are currently under investigation.
In contrast to the M 1 L variants, the M 1 H variants have been selected for an expanded receptor specificity, so they bind well to surfaces of new habitats, particularly where concentrations of soluble mannosylated compounds are relatively low, such as the urinary bladder (31) . Information regarding strains used for experimental UTI by other investigators is fully consistent with the hypothesis presented here that the M 1 H phenotype contributes more to pathogenesis than the M 1 L phenotype. E. coli strain 1177, recently shown to be a highly successful bladder colonizer (15), exhibits an M 1 H phenotype (20) . In contrast, E. coli 1066 that is clonally related to strain 1177 exhibits M 1 L phenotype and is a poor colonizer (15) . In another study on the use of FimH as a vaccine for cystitis E. coli (16) , the E. coli strain used in the experimental UTI model, Nu14, was a very successful colonizer of the murine bladder. This strain exhibits a distinct M 1 H phenotype (M 1 :M 3 ratio, 0.8). It will be important to determine whether anti-FimH antibodies protect equally against E. coli expressing M 1 H fimH and those expressing M 1 L fimH, as the pathogenesis of cystitis caused by low uroplaque-binding M 1 L variants could be different from that caused by more highly adhesive E. coli bearing the M 1 H phenotype.
Although M 1 H variants exhibit increased uropathogenicity, they are likely to be detrimental to transmission through the oral portal due to their increased sensitivity to salivary inhibitors and, therefore, would be less stable in the population than the M 1 L alleles. However, the M 1 H FimH alleles obviously can be spread between hosts to at least some extent. Uropathogens are actively disseminated into the environment via contaminated urine in the course of UTI. Also, it was shown previously that at least some uropathogenic E. coli isolates can be sexually transmitted between individuals (32). Possibly, acquisition of other adhesins, such as Dr, S, or P fimbriae, contributes to sustaining uropathogenic strains in the host population (33). Experimental support for each of these suppositions will require further detailed studies.
It must be noted that although the diversification of FimH alleles is obviously a result of within-host evolution of E. coli, it is not yet clear whether the uropathogenic M 1 H mutants are originally selected from M 1 L FimH-bearing E. coli occupying the colon or colonizing the urinary tract. It is also not clear whether the mutations of FimH alone could be sufficient for uropathogenicity. However, in this regard it should be noted that of nine virulence determinants analyzed in a recent study, the type 1 fimbrial gene cluster was often the only determinant present in the genetically diverse cystitis isolates tested (34) . It was the only determinant common to all isolates, and it was significantly more common than genes encoding, for instance, aerobactin, hemolysin, P fimbriae, or S fimbriae.
It has been previously proposed that more virulent clones of microorganisms emerge from nonvirulent (or less virulent) ancestral strains via within-host diversification (35) , possibly due to increased mutation rates (36, 37) . Although such studies have been based almost exclusively on theoretical models, considerable sequence diversity has been found in the hypervariable regions of the HIV-1 env gene of virions obtained from different organs of a patient (38) . It was hypothesized that genotypic diversification of the original clone transmitted to the individual might allow variants to invade and replicate in new habitats within an infected host but that such variants would not migrate effectively into new hosts. The genetic and functional characterization of the FimH proteins, provided here and in previous publications (19) (20) (21) , is the first direct example of allelic diversity leading to increased virulence and, at the same time, to decreased commensal fitness of a microorganism.
On the basis of these observations with allelic variants of FimH, a more generally applicable concept can be suggested: a variety of genes original to nonpathogenic microorganisms may be subject to mutations that are adaptive for the transition from commensal to pathologic habitats. Such pathogenicityadaptive, or pathoadaptive, mutations might be especially important for in-host microevolution of a pathogen during infections that are opportunistic and/or known to proceed from acute to chronic phases. Interestingly, these pathoadaptive mutations, as seems to be the case for FimH, may be detrimental for the original physiological role of the protein and may thus be under negative selection in the commensal niche. It is generally true that mutations affecting the specificity of the original function are most likely to be deleterious or abnormal for the organism in its evolutionarily primary niche (3). The most well known examples of this are the genetic disorders or predispositions to disorders in humans that result from mutations in certain genes, and for this reason allelic variations are becoming a major focus for the Human Genome Project. Now that the chromosomes of several human pathogens have been completely sequenced, attention of bacterial genome projects is turning toward identification of traits specialized for virulence. This search, however, is presently guided by the principle that genes adapted specifically for a pathologic habitat will be absent in nonpathogenic isolates. The concept of pathoadaptive variation of genes shared by commensals and pathogens provides an alternative approach for understanding bacterial virulence and suggests that bacterial genome projects should also be focused on functional analysis of structural variations in common genes.
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